Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer

Details for Australian Patent Application No. 2010271732 (hide)

Owner Japan Tobacco Inc.

Inventors Mitani, Ikuo; Ogoshi, Yosuke; Matsui, Takuya; Yokota, Masahiro; Terashita, Masakazu; Motoda, Dai; Ueyama, Kazuhito; Abe, Hiroyuki; Hotta, Takahiro; Ito, Takashi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010271732

PCT Pub. Number WO2011/007856

Priority 61/273,127 30.07.09 US; 2009-169565 17.07.09 JP

Filing date 16 July 2010

Wipo publication date 20 January 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/007856 Priority application(s): WO2011/007856

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010271746-2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl ]methyl]thio]-N-[4-(trifluoromethoxy) phenyl]-3-pyridinecarboxamide benzenesulfonate, crystals of same, polymorphs thereof, and processes for production thereof

2010271722-Pluripotent stem cell that can be isolated from body tissue